About us - CF PharmTech

Since 2007

CF PharmTech was founded in Jiangsu Province in 2007.

We focus on the field of respiratory diseases and have developed into a professional pharmaceutical company focused on the international market, integrating research and development, production and sales.

Our Mission

To provide medicines and solutions of clinical value to people through scientific discovery and innovation.
Our Vision

We are committed to becoming a global leader in the research and development, production and distribution of high-quality respiratory medicines.
Our Values

Be faithful and responsible, win-win cooperation;
Be innovative and diligent, continuous learning;
Performance first, strive for excellence.

Our History

2022

Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray(ShuFieMin ®) was approved for marketing.
2021

Budesonide Suspension for Inhalation(ChangQi ®) and Salbutamol Sulfate Inhalation Solution (ChangShu ®) were approved for marketing.
2020

Completed the F round of financing.
2019

Completed the E round of financing.
2017

Completed the D round of financing.
2015

Completed the C round of financing, started the construction of inhalation preparation production line and submitted the ANDA.
2013

Completed the B round of financing and established the Suzhou Changfeng Pharmaceutical.
2010

Completed the A round of financing and established the research and development center in Wuxi.
2007

CF PharmTech was founded.